603882 金域医学
交易中 12-19 14:20:35
资讯
新帖
简况
财信证券:给予金域医学买入评级,目标价位39.0元
证券之星 · 12-18 07:53
财信证券:给予金域医学买入评级,目标价位39.0元
金域医学12月17日主力资金流出67万元 连续3日减仓
市场透视 · 12-17 15:21
金域医学12月17日主力资金流出67万元 连续3日减仓
金域医学(603882)12月6日主力资金净买入2525.36万元
证券之星 · 12-07
金域医学(603882)12月6日主力资金净买入2525.36万元
金域医学新注册《金域BCR和TCR基因重排检测软件V1.0》等3个项目的软件著作权
证券之星 · 12-07
金域医学新注册《金域BCR和TCR基因重排检测软件V1.0》等3个项目的软件著作权
金域医学12月06日获主力加仓2242万元 环比增加2260.00%
市场透视 · 12-06
金域医学12月06日获主力加仓2242万元 环比增加2260.00%
金域医学涨5% 河南招标大增
智选洞察 · 12-06
金域医学涨5% 河南招标大增
金域医学新注册《金域样本级体细胞变异检测软件V1.0》等5个项目的软件著作权
证券之星 · 12-06
金域医学新注册《金域样本级体细胞变异检测软件V1.0》等5个项目的软件著作权
金域医学12月04日主力资金流出1446万元 连续3日减仓
市场透视 · 12-04
金域医学12月04日主力资金流出1446万元 连续3日减仓
金域医学11月28日主力资金流入57万元 连续3日加仓
市场透视 · 11-28
金域医学11月28日主力资金流入57万元 连续3日加仓
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
金域医学11月25日主力资金流出455万元 连续3日减仓
市场透视 · 11-25
金域医学11月25日主力资金流出455万元 连续3日减仓
金域医学跌5% 7家券商建议买入
智选洞察 · 11-22
金域医学跌5% 7家券商建议买入
金域医学(603882)11月21日主力资金净卖出1040.83万元
证券之星 · 11-22
金域医学(603882)11月21日主力资金净卖出1040.83万元
金域医学新注册《金域变异注释软件V3.0》项目的软件著作权
证券之星 · 11-22
金域医学新注册《金域变异注释软件V3.0》项目的软件著作权
金域医学新注册《金域集团流式湿实验自动化系统V1.0》项目的软件著作权
证券之星 · 11-22
金域医学新注册《金域集团流式湿实验自动化系统V1.0》项目的软件著作权
金域医学新注册《金域基因定量分析系统V1.2》项目的软件著作权
证券之星 · 11-21
金域医学新注册《金域基因定量分析系统V1.2》项目的软件著作权
金域医学新注册《金域基因突变分析系统V1.2》等2个项目的软件著作权
证券之星 · 11-20
金域医学新注册《金域基因突变分析系统V1.2》等2个项目的软件著作权
金域医学11月18日主力资金流出1211万元 连续5日减仓
市场透视 · 11-18
金域医学11月18日主力资金流出1211万元 连续5日减仓
核酸检测龙头,迎来政策暖风?
虎嗅APP · 11-14
核酸检测龙头,迎来政策暖风?
国信证券:金域医学常规检测收入增长承压,经营现金流净额环比改善
财中社 · 11-14
国信证券:金域医学常规检测收入增长承压,经营现金流净额环比改善
加载更多
公司概况
公司名称:
广州金域医学检验集团股份有限公司
所属行业:
卫生
上市日期:
2017-09-08
主营业务:
广州金域医学检验集团股份有限公司一家以第三方医学检验及病理诊断业务为核心的高科技服务企业,致力于为全国各级医疗机构提供符合国际标准的医学检验诊断信息整合服务。公司所提供的主要服务如下:医学检验及病理诊断类、非医学检验检测类、试剂销售、试剂生产、检验信息服务、医疗冷链物流。2023年,公司“健康哨兵五维质量管理模式”被收录在《21世纪中国质量管理最佳实践集萃》;金域医学30年质量经营哲学——《质量就是生命》成功出版,并入选“21世纪中国质量管理最佳实践系列丛书”,成为国内医学检测行业唯一代表。
发行价格:
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":31.17,"timestamp":1734589235000,"preClose":31.64,"halted":0,"volume":3497567,"delay":0,"floatShares":459999999,"shares":463000000,"eps":0.348,"marketStatus":"交易中","marketStatusCode":2,"change":-0.47,"latestTime":"12-19 14:20:35","open":31.3,"high":31.61,"low":30.9,"amount":109000000,"amplitude":0.0224,"askPrice":31.17,"askSize":48,"bidPrice":31.16,"bidSize":8,"shortable":0,"etf":0,"ttmEps":0.348,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734591600000},"adr":0,"adjPreClose":31.64,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":34.8,"lowLimit":28.48,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"pbRate":1.87,"roa":"--","roe":"1.16%","epsLYR":1.38,"committee":-0.153846,"marketValue":14440000000,"floatMarketCap":14342000000,"peRate":89.568968,"changeRate":-0.0149,"turnoverRate":0.0076,"status":1},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2492910323","title":"财信证券:给予金域医学买入评级,目标价位39.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492910323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492910323?lang=zh_cn&edition=full","pubTime":"2024-12-18 07:53","pubTimestamp":1734479591,"startTime":"0","endTime":"0","summary":"财信证券股份有限公司吴号近期对金域医学进行研究并发布了研究报告《经营业绩有望改善,数智化转型成效初显》,本报告对金域医学给出买入评级,认为其目标价位为39.00元,当前股价为31.57元,预期上涨幅度为23.54%。受益于精准医疗理念深入、检验技术进步等,国内ICL市场规模保持较快增长。最新盈利预测明细如下:该股最近90天内共有8家机构给出评级,买入评级7家,增持评级1家;过去90天内机构目标均价为41.8。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800007633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","161027"],"gpt_icon":0},{"id":"2492095302","title":"金域医学12月17日主力资金流出67万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492095302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492095302?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:21","pubTimestamp":1734420102,"startTime":"0","endTime":"0","summary":"12月17日, 金域医学股价跌1.19%,报收31.57元,成交金额1.66亿元,换手率1.14%,振幅2.32%,量比0.82。金域医学今日主力资金净流出67万元,连续3日净流出,上一交易日主力净流出426万元,今日环比减少84.27%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为66.67%,平均跌幅为2.43%。该股近5个交易日下跌7.12%,主力资金累计净流出624万元;近20日主力资金累计净流出6490万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217154951ab7e8317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217154951ab7e8317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","603882","BK0236","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2489929685","title":"金域医学(603882)12月6日主力资金净买入2525.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489929685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489929685?lang=zh_cn&edition=full","pubTime":"2024-12-07 08:18","pubTimestamp":1733530719,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月6日收盘,金域医学报收于34.34元,上涨3.19%,换手率2.44%,成交量11.23万手,成交额3.87亿元。12月6日的资金流向数据方面,主力资金净流入2525.36万元,占总成交额6.52%,游资资金净流出1485.92万元,占总成交额3.83%,散户资金净流出1039.44万元,占总成交额2.68%。金域医学主营业务:为全国超过23000家各类医疗机构提供包括质谱、基因组、病理、生化发光、免疫学、其他综合等11大类共87类医学检验技术,超4000项检验项目的外包及科研技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120700006901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","SG9999001069.SGD","BK0284","BK0042"],"gpt_icon":0},{"id":"2489256921","title":"金域医学新注册《金域BCR和TCR基因重排检测软件V1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2489256921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489256921?lang=zh_cn&edition=full","pubTime":"2024-12-07 01:19","pubTimestamp":1733505554,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了3个项目的软件著作权,包括《金域BCR和TCR基因重排检测软件V1.0》、《金域线粒体DNA拷贝数检测软件V1.0》、《金域样本级遗传变异检测软件V1.0》等。今年以来金域医学新注册软件著作权45个,较去年同期增加了2.27%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.97亿元,同比减22.59%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120700001566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","BK0042","603882","BK0236"],"gpt_icon":0},{"id":"2489864512","title":"金域医学12月06日获主力加仓2242万元 环比增加2260.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489864512","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489864512?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:20","pubTimestamp":1733469645,"startTime":"0","endTime":"0","summary":"12月06日, 金域医学股价涨3.19%,报收34.34元,成交金额3.87亿元,换手率2.44%,振幅5.68%,量比1.74。金域医学今日主力资金净流入2242万元,上一交易日主力净流入95万元,今日环比增加2260.00%。该股近5个交易日上涨6.51%,主力资金累计净流出2098万元;近20日主力资金累计净流出8676万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153858a1d88b60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153858a1d88b60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","BK0042","BK0284","SG9999001069.SGD","603882"],"gpt_icon":0},{"id":"2489442496","title":"金域医学涨5% 河南招标大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2489442496","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489442496?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:34","pubTimestamp":1733448878,"startTime":"0","endTime":"0","summary":"12月06日,金域医学股价大幅上涨,截至09点34分,金域医学上涨5.29%,报35.04元/股,成交4830万元,换手率0.30%,振幅5.29%。消息解读11月份河南省完成医疗器械及相关服务招标和中标项目共计867个,总金额规模为18.25亿元。资金动向截止发稿,金域医学获得主力净流出18万元,其中超大单流出208万元,大单流入191万元。最新财报显示,今年三季报,金域医学实现营业收入56.19亿元,同比减少10.95%,净利润为9,383.90万元,同比减少83.71%,基本每股收益为0.20元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093509a1d7d20f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093509a1d7d20f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","603882","SG9999001069.SGD","BK0236","BK0284"],"gpt_icon":0},{"id":"2489460232","title":"金域医学新注册《金域样本级体细胞变异检测软件V1.0》等5个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2489460232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489460232?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:13","pubTimestamp":1733418795,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了5个项目的软件著作权,包括《金域样本级体细胞变异检测软件V1.0》、《金域生信流程统一管理软件V1.0》、《金域RNA-seq融合基因检测软件V1.0》、《金域WGS-SV分析流程软件V1.0.4》、《金域α地贫基因分型软件V1.0》等。今年以来金域医学新注册软件著作权41个,较去年同期减少了6.82%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.97亿元,同比减22.59%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600000657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","603882","BK0284","BK0042","BK0236"],"gpt_icon":0},{"id":"2488481153","title":"金域医学12月04日主力资金流出1446万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2488481153","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488481153?lang=zh_cn&edition=full","pubTime":"2024-12-04 15:20","pubTimestamp":1733296807,"startTime":"0","endTime":"0","summary":"12月04日, 金域医学股价跌2.81%,报收32.53元,成交金额1.46亿元,换手率0.97%,振幅3.50%,量比0.74。金域医学今日主力资金净流出1446万元,连续3日净流出,上一交易日主力净流出1145万元,今日环比增加26.29%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为72.22%,平均跌幅为2.31%。该股近5个交易日上涨1.72%,主力资金累计净流出4197万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1.29亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204153726a26b84a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204153726a26b84a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","SG9999001069.SGD","BK0284","BK0042","BK0236"],"gpt_icon":0},{"id":"2486936503","title":"金域医学11月28日主力资金流入57万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486936503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486936503?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:18","pubTimestamp":1732778308,"startTime":"0","endTime":"0","summary":"11月28日, 金域医学股价跌1.59%,报收31.47元,成交金额1.37亿元,换手率0.94%,振幅2.28%,量比0.74。金域医学今日主力资金净流入57万元,连续3日净流入,上一交易日主力净流入186万元,今日环比减少69.35%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为11.11%,平均涨幅为4.92%。该股近5个交易日下跌5.15%,主力资金累计净流出692万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出7003万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128152443abe534d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128152443abe534d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","BK0042","603882","BK0284","SG9999001069.SGD"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486716147","title":"金域医学11月25日主力资金流出455万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486716147","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486716147?lang=zh_cn&edition=full","pubTime":"2024-11-25 15:21","pubTimestamp":1732519270,"startTime":"0","endTime":"0","summary":"11月25日, 金域医学股价涨0.45%,报收31.59元,成交金额2.04亿元,换手率1.40%,振幅4.83%,量比1.10。金域医学今日主力资金净流出455万元,连续3日净流出,上一交易日主力净流出884万元,今日环比减少48.53%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为76.47%,平均跌幅为2.31%。该股近5个交易日下跌2.35%,主力资金累计净流出3880万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出2.47亿元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125154329abdd2a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125154329abdd2a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","BK0236","SG9999001069.SGD","BK0042","BK0284"],"gpt_icon":0},{"id":"2485281684","title":"金域医学跌5% 7家券商建议买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2485281684","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485281684?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:54","pubTimestamp":1732258474,"startTime":"0","endTime":"0","summary":"11月22日,金域医学股价大幅下跌,截至14点54分,金域医学下跌5.12%,报31.48元/股,成交1.80亿元,换手率1.21%,振幅5.06%。此外,数据统计显示,近半年内2家券商给予增持建议,7家券商给予买入建议。资金动向截止发稿,金域医学获得主力净流出805万元,其中超大单流出1411万元,大单流入606万元。最新财报显示,今年三季报,金域医学实现营业收入56.19亿元,同比减少10.95%,净利润为9,383.90万元,同比减少83.71%,基本每股收益为0.20元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145627abd6a347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145627abd6a347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","BK0284","603882","BK0042","SG9999001069.SGD"],"gpt_icon":0},{"id":"2485765634","title":"金域医学(603882)11月21日主力资金净卖出1040.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485765634","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485765634?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:24","pubTimestamp":1732235085,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月21日收盘,金域医学报收于33.18元,下跌1.69%,换手率1.18%,成交量5.45万手,成交额1.81亿元。融券方面,融券卖出100.0股,融券偿还0.0股,融券余量8.78万股,融券余额291.32万元。金域医学主营业务:为全国超过23000家各类医疗机构提供包括质谱、基因组、病理、生化发光、免疫学、其他综合等11大类共87类医学检验技术,超4000项检验项目的外包及科研技术服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200007242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0284","SG9999001069.SGD","BK0236","BK0042"],"gpt_icon":0},{"id":"2485105834","title":"金域医学新注册《金域变异注释软件V3.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485105834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485105834?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:18","pubTimestamp":1732209497,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了《金域变异注释软件V3.0》项目的软件著作权。今年以来金域医学新注册软件著作权31个,较去年同期减少了26.19%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.97亿元,同比减22.59%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200000819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","BK0042","603882","BK0236"],"gpt_icon":0},{"id":"2485105694","title":"金域医学新注册《金域集团流式湿实验自动化系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485105694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485105694?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:18","pubTimestamp":1732209496,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了《金域集团流式湿实验自动化系统V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权31个,较去年同期减少了26.19%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.97亿元,同比减22.59%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200000820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","603882","SG9999001069.SGD","BK0284","BK0042"],"gpt_icon":0},{"id":"2485401571","title":"金域医学新注册《金域基因定量分析系统V1.2》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485401571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485401571?lang=zh_cn&edition=full","pubTime":"2024-11-21 01:13","pubTimestamp":1732122791,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了《金域基因定量分析系统V1.2》项目的软件著作权。今年以来金域医学新注册软件著作权29个,较去年同期减少了30.95%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.97亿元,同比减22.59%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100000566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","603882","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2484497858","title":"金域医学新注册《金域基因突变分析系统V1.2》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2484497858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484497858?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:07","pubTimestamp":1732036030,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了2个项目的软件著作权,包括《金域基因突变分析系统V1.2》、《流式血液病结果录入系统V1.0》等。今年以来金域医学新注册软件著作权28个,较去年同期减少了33.33%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了1.97亿元,同比减22.59%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000000490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","BK0284","SG9999001069.SGD","603882"],"gpt_icon":0},{"id":"2484614420","title":"金域医学11月18日主力资金流出1211万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484614420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484614420?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:21","pubTimestamp":1731914462,"startTime":"0","endTime":"0","summary":"11月18日, 金域医学股价跌2.18%,报收32.35元,成交金额1.71亿元,换手率1.14%,振幅3.45%,量比0.44。金域医学今日主力资金净流出1211万元,连续5日净流出,上一交易日主力净流出1437万元,今日环比减少15.73%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为66.67%,平均跌幅为1.87%。该股近5个交易日下跌6.83%,主力资金累计净流出6001万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出2.31亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154414a242345e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154414a242345e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","BK0042","BK0236","SG9999001069.SGD","BK0284"],"gpt_icon":0},{"id":"2483782725","title":"核酸检测龙头,迎来政策暖风?","url":"https://stock-news.laohu8.com/highlight/detail?id=2483782725","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483782725?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:53","pubTimestamp":1731581612,"startTime":"0","endTime":"0","summary":"相对应,相关企业有望加快收回政府拖欠的应收账款,减少坏账,利润情况有望改善。要注意的是,当下新冠检测业务涉及的应收账款金额仍较高。其中,新冠核酸检测是针对新冠病毒,核酸是基因序列,理论上也是市场需求量并不大的特检项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114185808abc0db48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114185808abc0db48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","603882","BK0236","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2483843580","title":"国信证券:金域医学常规检测收入增长承压,经营现金流净额环比改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2483843580","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483843580?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:52","pubTimestamp":1731567166,"startTime":"0","endTime":"0","summary":"公司进一步加强现金流管理力度,应收账款回收进度改善明显,前三季度公司经营活动现金流量净额为3.12亿,其中三季度经营现金流净额为2.78亿,同比增长80%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114150911abbffed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114150911abbffed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0183","SG9999001069.SGD","BK0028","BK0284","BK0188","BK0236","603882","002736","BK0276","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","stockEarnings":[{"period":"1week","weight":-0.0767},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.1598},{"period":"6month","weight":0.126},{"period":"1year","weight":-0.4802},{"period":"ytd","weight":-0.4793}],"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","perCapita":"13507股","boardName":"卫生","registeredCapital":"46325万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":" 广州金域医学检验集团股份有限公司一家以第三方医学检验及病理诊断业务为核心的高科技服务企业,致力于为全国各级医疗机构提供符合国际标准的医学检验诊断信息整合服务。公司所提供的主要服务如下:医学检验及病理诊断类、非医学检验检测类、试剂销售、试剂生产、检验信息服务、医疗冷链物流。2023年,公司“健康哨兵五维质量管理模式”被收录在《21世纪中国质量管理最佳实践集萃》;金域医学30年质量经营哲学——《质量就是生命》成功出版,并入选“21世纪中国质量管理最佳实践系列丛书”,成为国内医学检测行业唯一代表。","serverTime":1734589239114,"listedPrice":6.93,"stockholders":"34066人(较上一季度减少1.95%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}